---
schema_version: "secwatch.filing_event.v1"
accession: "0001750155-26-000028"
form_type: "8-K"
ticker: "CWBHF"
cik: "0001750155"
company_name: "Charlotte's Web Holdings, Inc."
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:12:16.065267+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Charlotte's Web Q4 rev $13.3M (+4.7% YoY), net loss $11.5M; announces BAT debenture conversion & CMMI pilot

## Summary
- Q4 2025 revenue $13.3M, up 4.7% YoY; net loss $11.5M ($0.07 loss per share).
- Full-year 2025 revenue $49.9M (+0.5% YoY); net loss $29.7M ($0.19 per share).
- BAT to convert C$75.3M debenture + $10M new equity, holding ~40% of shares; subject to TSX and shareholder approval.
- Charlotte's Web selected as CBD launch partner for CMMI Medicare pilot; CMS BEI guidance allows up to $500/beneficiary annually starting April 2026.
- DeFloria (33% owned) cleared by FDA for Phase 2 trial of AJA001 for autism irritability; expects mid-2026 start.

## SEC filing metadata
- accession: 0001750155-26-000028
- form_type: 8-K
- ticker: CWBHF
- cik: 0001750155
- company_name: Charlotte's Web Holdings, Inc.
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750155/000175015526000028/0001750155-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750155/000175015526000028/cweb-20260331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001750155-26-000028
- JSON: https://secwatch.observer/filing/0001750155-26-000028.json
- Plain text: https://secwatch.observer/filing/0001750155-26-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.